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Objectives. We examined by thallium-201 scintigraphy whether
exercise-induced abnormal blood pressure response (BPR) is
related to myocardial ischemia.
Background. Hemodynamic instabilities during exercise in
patients with hypertrophic cardiomyopathy (HCM) are consid-
ered to be caused by abnormal reflex control of vascular resis-
tance.
Methods. In 105 patients with HCM, exercise thallium scintig-
raphy was performed by means of a multistage, symptom-limited
bicycle ergometer exercise test.
Results. Eighty-eight patients had normal BPR (>225 mm Hg
from baseline to peak exercise), and 17 had abnormal BPR
(<25 mm Hg). Clinical characteristics including age, the preva-
lence of obstruction, New York Heart Association functional class
and echocardiographic measurements were similar between the
two groups. Left ventricular end-diastolic pressure was signifi-
cantly higher in patients with abnormal BPR than in those with
normal BPR (18 6 8 vs. 14 6 5 mm Hg, p < 0.05). Exercise-
induced perfusion abnormalities including fixed and reversible
perfusion defects, and left ventricular cavity dilatation (LVCD)
were identified in 72 (69%) of 105 study patients. Left ventricular
cavity dilatation indicates subendocardial hypoperfusion and is a
marker of diffuse subendocardial ischemia. The prevalence of
fixed or reversible perfusion defects was similar between the two
groups. Patients with abnormal BPR had the higher prevalence of
LVCD as compared to those with normal BPR (47.1 vs. 10%, p <
0.0002). Multiple logistic regression analysis revealed that LVCD
was independently associated with abnormal BPR (odds ratio
3.76, 95% confidence interval 1.61 to 8.76).
Conclusions. Exercise-induced abnormal BPRs in patients with
HCM are related to subendocardial ischemia during exercise.
(J Am Coll Cardiol 1998;32:1938–42)
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Patients with hypertrophic cardiomyopathy (HCM) have he-
modynamic instabilities with abnormal blood pressure re-
sponse (BPR) during exercise (1,2). The possible mechanism is
considered to be due to a fall in systemic vascular resistance
during exercise (1,2). Myocardial ischemia commonly occurs in
patients with HCM despite normal epicardial coronary arter-
ies. It is possible that abnormal BPRs are related to myocardial
ischemia. This issue has never been investigated. Thallium-201
single photon emission computed tomography is a noninvasive
method with which we are able to evaluate myocardial isch-
emia during exercise. Left ventricular cavity dilatation
(LVCD) during exercise on thallium scintigrams indicates
subendocardial hypoperfusion and is a marker of diffuse
subendocardial ischemia (3,4). To assess the relationship be-
tween abnormal BPR and subendocardial ischemia in HCM,
we therefore performed exercise thallium-201 single photon
emission computed tomography in patients with HCM who
had normal or abnormal BPRs during exercise testing.
Methods
Study patients. The study population consisted of 105
patients with HCM who were initially diagnosed at the Ku-
rume University Hospital. They were 84 men and 31 women
(13 to 77 years old, mean 48 years). The diagnosis of HCM was
based on the typical clinical, electrocardiographic and hemo-
dynamic features with echocardiographic demonstration of a
nondilated, asymmetrically hypertrophied left ventricle in the
absence of other cardiac or systemic diseases that could
produce left ventricular hypertrophy (5). In all patients, car-
diac catheterization, including left ventricular and selective
coronary angiograms and exercise thallium-201 studies, was
performed. The following patients were excluded from this
study: patients who had valvular heart disease, coronary artery
disease with significant atherosclerotic lesion, history of sys-
temic hypertension .160/90 mm Hg and severe symptoms
(New York Heart Association functional class IV). These
studies were approved by our institutional ethic committees,
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and informed consent for the study was obtained from all
patients.
Exercise thallium single photon emission computed tomo-
graphic imaging. Cardioactive medicines were discontinued
at least for five half-lives before the present study. After an
overnight fast, exercise thallium scintigraphy was performed by
means of a multistage, symptom-limited bicycle ergometer
exercise test with continuous monitoring of symptoms, electro-
cardiogram and heart rate. Systolic blood pressure was peri-
odically measured at 1-min interval at rest, during exercise and
during the initial 5 min of the recovery period. Measurements
were made by digital palpation of the brachial artery using a
mercury sphygmomanometer. At peak exercise, patients intra-
venously received 3 mCi of thallium-201, and exercise was
continued for an additional period of 60 s to allow adequate
circulation of the isotope. The exercise test was terminated
when there was ischemic ST segment depression .0.2 mV,
significant arrhythmia, moderate or severe chest pain, signifi-
cant hypotension, excessive fatigue, shortness of breath or
achievement of 100% of the maximal predicted heart rate. As
previously described (6), abnormal BPR was defined as the
failure for systolic BPR to increase by $25 mm Hg from the
resting value.
Thallium imaging was begun within 10 min of the comple-
tion of exercise and repeated after 4 h. The studies were
performed with a rotating gamma camera of a wide field of
view equipped with a low energy, medium resolution, high
sensitivity and parallel hole collimator (RC-1500I, Hitachi)
centered on the 70-KeV photopeak with a 10% window. The
camera was rotated over a 180° arc in an elliptical orbit about
the patient’s anterior thorax from 45° right anterior oblique to
45° left posterior oblique position. Thirty-two images were
obtained in a 64 3 64 matrix for 30 s. For image reconstruc-
tion, thallium images were processed on an image-analyzing
system (RW 3000, Hitachi). Then, reconstruction was per-
formed using a Butterworth filter with a cutoff frequency of
0.25 cycles/pixel and an order of 8. No attenuation or scatter
correction was employed.
Image analysis. The initial and delayed tomographic im-
ages were interpreted by three experienced observers who had
no knowledge of the present study design. For each study, the
observers evaluated two short axis slices (basal and midven-
tricular) and one midvertical long axis slice. The basal and
midventricular short axis slices were divided into six segments
each. In the vertical long axis slice, one apical segment was
chosen. Then, a total of 13 segments per patient were evalu-
ated in this study. The degree of radiotracer uptake for each of
the 13 segments was semiquantitatively assessed using a five-
point scoring system modified from the previous method (4,7).
Regional thallium uptake was graded from 0 to 4, in incre-
ments of 1 with a score of 4 signifying normal activity and a
score of 0 signifying absent activity. Perfusion abnormalities
were defined as fixed or reversible perfusion defects and
exercise-induced LVCD. Scores for each segment were aver-
aged; no change from the exercise to the redistribution study
was considered a fixed perfusion defect, and a change of 1 or
more from the exercise to the redistribution study was consid-
ered a reversible perfusion defect. LVCD was assessed quali-
tatively (4) and determined to be absent or present by inde-
pendent observers unaware of the study protocol.
Statistical analysis. Data were expressed as mean value 6
SD or percentages. Comparisons between groups of patients
were performed with the two-tailed, unpaired Student t test.
Differences in proportions were analyzed with the chi-square
test or Fisher’s exact test. A multiple logistic regression
analysis was performed to assess independent influencing
factors for BPR during exercise, with the normal or abnormal
BPR as a dependent variable. The following variables were
used as possible influencing factors: age, gender, left ventric-
ular outflow obstruction, family history of sudden cardiac
death, history of chest pain, cardiothoracic ratio, electrocar-
diographic and echocardiographic findings, hemodynamic
data, and scintigraphic findings. Differences were considered
statistically significant when the probability was less than 0.05.
Results
Clinical characteristics of patients with normal or abnor-
mal BPR during exercise testing. Clinical characteristics of
patients with normal or abnormal BPRs during exercise testing
are shown in Table 1. The two groups did not differ in terms of
the age, gender, presence of the left ventricular outflow
obstruction, family history, history of chest pain, New York
Heart Association functional class, cardiothoracic ratio, elec-
trocardiographic and echocardiographic findings. However,
patients with abnormal BPR had greater left ventricular end-
diastolic pressure (LVEDP) at rest than those with normal
BPR (p , 0.05). Exercise tolerance, heart rate-pressure prod-
uct and difference between peak and rest systolic blood
pressure were significantly lower in patients with abnormal
BPR than in patients with normal BPR (p , 0.05).
Thallium-201 emission computed tomography. Perfusion
abnormalities were identified in 72 (69%) of the 105 study
patients. Of the perfusion abnormalities, fixed and reversible
perfusion defects, and LVCD were observed in 31 (30%), 63
(60%) and 17 patients (16%), respectively. When patients were
divided into the two groups of normal or abnormal BPR during
exercise testing (Table 2), patients with abnormal BPR had the
higher prevalence of LVCD as compared to those with normal
BPR (p , 0.0002). However, the two groups did not differ in
terms of the fixed or reversible perfusion defects. There were
no differences in locations of fixed or reversible perfusion
defect between the two groups (data not shown). Of the
Abbreviations and Acronyms
BPR 5 blood pressure response
HCM 5 hypertrophic cardiomyopathy
LVCD 5 left ventricular cavity dilatation
LVEDP 5 left ventricular end-diastolic pressure
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patients who had both abnormal BPR and perfusion abnor-
malities, patients (n 5 8) with LVCD had more elevated
LVEDP as compared to those (n 5 5) without LVCD (20 6 8
vs. 10 6 2 mm Hg, p , 0.03). Figure 1 shows representative
thallium tomographic images of LVCD in a patient with HCM
who had abnormal BPR during exercise testing.
Multiple logistic regression analysis. By multiple logistic
regression analysis corrected for possible influencing factors,
LVCD on thallium scintigraphy was independently associated
with abnormal BPR (odds ratio 3.76, 95% confidence interval
1.61 to 8.76, p 5 0.0022).
Discussion
The major findings of this study were that HCM patients
with abnormal BPR during exercise had the greater LVEDP
and higher prevalence of LVCD on thallium scintigraphy.
Table 1. Clinical Characteristics of Study Patients With Normal and Abnormal BPR During Exercise
Normal BPR Abnormal BPR
Number of cases (male/female) 88 (64/24) 17 (10/7)
Age (years) 49 6 17 45 6 18
Obstructive HCM (%) 11 (12.5) 2 (11.8)
Family history of HCM (%) 29 (34.0) 7 (41.2)
Family history of sudden cardiac death (%) 10 (11.3) 4 (23.5)
History of chest pain (%) 29 (33) 6 (35)
NYHA functional class I/II/III (%) 31 (35.2)/53 (60.2)/4 (4.5) 5 (29.4)/11 (64.7)/1 (5.9)
Cardiothoracic ratio (%) 50 6 6 51 6 5
Electrocardiogram
SV# 1 1 RV# 5 (mV) 3.9 6 1.5 3.7 6 1.7
Echocardiogram
Interventricular septal thickness (mm) 17 6 6 16 6 7
Posterior wall thickness (mm) 12 6 3 13 6 4
Left ventricular end-diastolic diameter (mm) 45 6 6 46 6 11
Left ventricular end-systolic diameter (mm) 28 6 7 30 6 11
Fractional shortening (%) 37 6 9 36 6 11
Hemodynamics
LVEDP (mm Hg) 14 6 5 18 6 8*
Exercise test
Exercise tolerance (METs) 6.7 6 1.5 5.8 6 1.7*
Heart rate–pressure product at peak exercise (3103) 26 6 5.2 18 6 4.7*
Difference between peak and rest systolic blood
pressure (mm Hg)
65 6 24 19 6 9*
ST depression $1 mm (%) 25 (28.4) 8 (47.1)
*p , 0.05 compared with normal BPR. Data are presented as mean 6 SD or number (%) of patients. BPR 5 blood
pressure response; HCM 5 hypertrophic cardiomyopathy; LVEDP 5 left ventricular end-diastolic pressure; METs 5
metabolic equivalents of oxygen consumption; NYHA 5 New York Heart Association; SV# 1 5 S-wave voltage in lead V# 1;
RV# 5 5 R-wave voltage in lead V# 5.
Table 2. Prevalence and Type of Perfusion Abnormalities in
Patients With Normal and Abnormal BPR
Normal BPR
(n 5 88)
Abnormal BPR
(n 5 17)
Abnormal perfusion imagings (%) 59 (67.1) 13 (76.5)
Fixed perfusion defects (%) 24 (27.3) 7 (41.2)
Reversible perfusion defects (%) 52 (59.1) 11 (64.7)
Left ventricular cavity dilatation (%) 9 (10.2) 8 (47.1)*
Normal perfusion imagings (%) 29 (32.9) 4 (23.5)
*p , 0.0002 compared with normal BPR. Abbreviation as in Table 1.
Figure 1. Stress (top) and delayed (bottom) thallium tomographic
images of the heart of a patient with hypertrophic cardiomyopathy who
had abnormal blood pressure response during exercise testing. Note
that stress images demonstrate apparent left ventricular cavity dilata-
tion in the basal, midventricular short axis and vertical long axis slices.
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Relation of thallium perfusion abnormalities to abnormal
BPR during exercise. We assessed myocardial perfusion ab-
normalities during exercise with thallium scintigraphy in pa-
tients with HCM. Previous studies have shown that the prev-
alence of perfusion abnormalities ranges from 52 to 74% in
patients with HCM (4,8,9). In the present study, the prevalence
of perfusion abnormalities, including perfusion defects (fixed
and reversible) and LVCD, was 69%. Thus, the present study
confirms that perfusion abnormalities are common in patients
with HCM. It is generally considered in patients with HCM
that fixed perfusion defects may represent regional myocardial
fibrosis and scarring (8,10), whereas reversible perfusion de-
fects may represent regional myocardial ischemia (4,8,9).
Although many patients had fixed or reversible perfusion
defects in the present study, these perfusion abnormalities
were not due to coronary artery disease of large epicardial
arteries, because all patients had normal epicardial coronary
arteries by coronary angiography. Therefore, the genesis of
these regional perfusion abnormalities was not clarified in this
study. In the present study, the prevalence of either fixed or
reversible perfusion defect was similar between the patient
groups with normal and abnormal BPRs. Thus, it is unlikely
that abnormal BPR in HCM was related to regional myocar-
dial fibrosis, scarring or ischemia.
LVCD assessed by thallium scintigraphy indicates ischemia-
related subendocardial hypoperfusion, because this scinti-
graphic abnormality occurs in the absence of any significant
changes in left ventricular cavity size by radionuclide angiog-
raphy (4). Previous studies have shown that LVCD on thallium
scintigraphy is an indication of severe multivessel disease in
patients with coronary artery disease (3). Scintigraphic findings
of LVCD are supported by the concordance of lactate meta-
bolic abnormalities during pacing stress in HCM (4). Thus,
although we have no other evidence of myocardial ischemia, it
is likely that LVCD indicates diffuse subendocardial ischemia
in our study patients. The mechanisms responsible for suben-
docardial ischemia in HCM are unknown. Proposed possible
mechanisms are structural abnormalities of intramural small
coronary arteries (11,12), distribution of fibrous and hypertro-
phied tissue formation in the left ventricular myocardium (13),
limitation of coronary flow reserve (14–16), impairment of
diastolic filling (17,18) and presence of left ventricular outflow
obstruction (19,20). These histologic and hemodynamic abnor-
malities could potentially induce inadequacy of myocardial
blood flow and increase in myocardial oxygen demand during
exercise stress, resulting in subendocardial ischemia. Although
we did not specifically examined mechanisms of subendocar-
dial ischemia in this study, left ventricular obstruction was not
likely, because the prevalence of obstruction was similar be-
tween patients with LVCD and without LVCD (10% vs. 12%).
It is possible that impairment of diastolic filling was responsi-
ble, because LVEDP was higher in patients with LVCD than in
those without LVCD (20 6 8 vs. 10 6 2 mm Hg). However,
this was speculative, because we did not measure LVEDP
during exercise in this study.
Possible role of subendocardial ischemia in exercise-
induced abnormal BPR. It has been proposed that the mech-
anism of exercise-induced abnormal BPR is due to abnormal-
ities of vascular function in systemic vascular resistance during
exercise stress (1,2). In this study, abnormal BPR was unlikely
due to systolic dysfunction or left ventricular obstruction,
because fractional shortening and the prevalence of obstruc-
tion were similar between the patients with and without
abnormal BPRs. The relation of exercise-induced abnormal
BPR to myocardial ischemia in HCM has not been investi-
gated. In the present study, patients with abnormal BPR had
the significantly higher prevalence of LVCD as compared to
those with normal BPR. The two groups did not differ in terms
of the fixed or reversible perfusion defect. Thus, these findings
indicate that exercise-induced abnormal BPR are related to
diffuse subendocardial ischemia rather than regional myocar-
dial fibrosis and scarring or ischemia. The patients with
abnormal BPR had the higher LVEDP at rest. Cannon et al
have demonstrated significant elevations in LVEDP after
pacing stress in patients with LVCD during exercise test (4).
Thus, it is feasible to think that patients with abnormal BPR
had even higher filling pressures during exercise, resulting in
less coronary perfusion pressure, which would cause diffuse
subendocardial ischemia. Therefore, the present findings sug-
gest that, in patients with LVCD, exercise-induced abnormal
BPR may be related to development of subendocardial isch-
emia in association with further elevation in LVEDP during
exercise.
It is not clear from our study how subendocardial ischemia
and abnormal BPR are related. It has been reported that
cardiac output is normal during exercise in HCM patients with
abnormal BPR (1). Thus, it is not likely that ischemia-induced
cardiac dysfunction with low cardiac output contributed to
abnormal BPR. A previous study by Lele et al has demon-
strated that an abnormal vasodilator response, which is caused
by a centrally mediated reflex triggered by ventricular barore-
ceptor stimulation, may be the cause of exercise-induced
hypotension in some patients with ischemic heart disease (21).
These findings suggest that myocardial ischemia may be one of
the stimuli responsible for the reflex-mediated vasodilator
response. Accordingly, ischemia-induced abnormal neurocar-
diogenic reflex may have played a role in abnormal BPR in our
patients. This possibility needs to be further investigated. On
the contrary, it is possible that exercise-induced abnormal BPR
(hypotension) may have aggravated ongoing myocardial isch-
emia during exercise.
Limitations. In the present study, systolic blood pressure
during exercise testing was measured by digital palpation of the
brachial artery. Accordingly, palpation of blood pressure might
have led to erroneous measurements, particularly during stren-
uous exercise.
Clinical implications. The present study provides several
clinical implications. Evidence of inducible ischemia by thal-
lium scintigraphy has been shown to be related to a history of
cardiac arrest or syncope (22), and to potentially lethal ar-
rhythmias (23), which are risk factors for sudden cardiac death
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in patients with HCM. Recently, we and others have demon-
strated that exercise-induced abnormal BPR is a strong pre-
dictor for sudden cardiac death in HCM (6,24). Furthermore,
the present study has shown that LVCD is independently
associated with abnormal BPR. Taken together, scintigraphic
evidence of LVCD associated with exercise-induced abnormal
BPR in HCM patients may be useful for identifying high risk
patients for sudden cardiac death.
Conclusions. The present study demonstrated for the first
time that exercise-induced abnormal BPR may be related to
the development of subendocardial ischemia in patients with
HCM. Our findings may contribute to understanding of the
pathophysiologic association between myocardial ischemia and
altered exercise hemodynamics in HCM.
References
1. Frenneaux MP, Counihan PJ, Caforio ALP, Chikamori T, McKenna WJ.
Abnormal blood pressure response during exercise in hypertrophic cardio-
myopathy. Circulation 1990;82:1995–2002.
2. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular
responses to supine exercise in hypertrophic cardiomyopathy. Circulation
1991;84:686–96.
3. Ritchie J, Bateman T, Bonow R, et al. Guidelines for clinical use of cardiac
radionuclide imaging: a report of the American Heart Association/American
College of Cardiology task force on assessment of diagnostic and therapeutic
cardiovascular procedures, committee on radionuclide imaging, developed in
collaboration with the American Society of Nuclear Cardiology. Circulation
1995;91:1278–303.
4. Cannon RO, Dilsizian V, O’gara PT, et al. Myocardial metabolic, hemody-
namic, and electrocardiographic significance of reversible thallium-201 ab-
normalities in hypertrophic cardiomyopathy. Circulation 1991;83:1660–7.
5. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of
nomenclature. Am J Cardiol 1979;43:1242–4.
6. Maki S, Ikeda H, Muro A, et al. Predictors of sudden cardiac death in
hypertrophic cardiomyopathy. Am J Cardiol 1998;82:774–8.
7. Okada RD, Boucher CA, Kirshenbaum HK, et al. Improved diagnostic
accuracy of thallium-201 stress test using multiple observers and criteria
derived from interobserver analysis of variance. Am J Cardiol 1980;46:619–
24.
8. O’gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities
in patients with hypertrophic cardiomyopathy: assessment with thallium-201
emission computed tomography. Circulation 1987;76:1214–23.
9. Udelson JE, Bonow RO, O’Gara PT, et al. Verapamil prevents silent
myocardial perfusion abnormalities during exercise in asymptomatic patients
with hypertrophic cardiomyopathy. Circulation 1989;79:1052–60.
10. Nagata S, Park Y, Minamikawa T, et al. Thallium perfusion and cardiac
enzyme abnormalities in patients with familial hypertrophic cardiomyopathy.
Am Heart J 1985;109:1317–22.
11. Maron B, Epstein S, Roberts W. Hypertrophic cardiomyopathy and trans-
mural myocardial infarction without significant atherosclerosis of the extra-
mural coronary arteries. Am J Cardiol 1979;43:1086–102.
12. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (“small
vessel”) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll
Cardiol 1986;8:545–57.
13. Opherk D, Mall G, Zebe H, et al. Reduction of coronary reserve: a
mechanism for angina pectoris in patients with arterial hypertension and
normal coronary arteries. Circulation 1984;69:71–9.
14. Cannon RO, Rosing DR, Maron BJ, et al. Myocardial ischemia in patients
with hypertrophic cardiomyopathy: contribution of inadequate vasodilator
reserve and elevated left ventricular filling pressures. Circulation 1985;71:
234–43.
15. Ogata Y, Hiyamuta K, Terasawa M, et al. Relationship of exercise or pacing
induced ST segment depression and myocardial lactate metabolism in
patients with hypertrophic cardiomyopathy. Jpn Heart J 1986;27:145–58.
16. Ikeda H, Shimamatsu M, Yoshiga O, Shibao K, Koga Y, Toshima H.
Impaired myocardial perfusion in patients with hypertrophic cardiomyopa-
thy: assessment with digital subtraction coronary arteriography. Heart
Vessels 1988;4:170–8.
17. Brutsaert D, Rademakers F, Sys S. Triple control of relaxation: implications
in cardiac disease. Circulation 1984;69:190–6.
18. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV.
Verapamil-induced improvement in left ventricular diastolic filling and
increased exercise tolerance in patients with hypertrophic cardiomyopathy:
short- and long-term effects. Circulation 1985;72:853–64.
19. Wigle E, Sasson Z, Henderson M, et al. Hypertrophic cardiomyopathy: the
importance of the site and the extent of hypertrophy. A review. Prog
Cardiovasc Dis 1985;28:1–83.
20. Cannon RO, Schenke WH, Maron BJ, et al. Differences in coronary flow and
myocardial metabolism at rest and during pacing between patients with
obstructive and patients with nonobstructive hypertrophic cardiomyopathy.
J Am Coll Cardiol 1987;10:53–62.
21. Lele SS, Scalia G, Thomson H, et al. Mechanism of exercise hypotension in
patients with ischemic heart disease. Role of neurocardiogenically mediated
vasodilation. Circulation 1994;90:2701–9.
22. Dilsizian V, Bonow RO, Epstein SE, Fananapazir L. Myocardial ischemia
detected by thallium scintigraphy is frequently related to cardiac arrest and
syncope in young patients with hypertrophic cardiomyopathy. J Am Coll
Cardiol 1993;22:796–804.
23. von Dohlen TW, Prisant LM, Frank MJ. Significance of positive or negative
thallium-201 scintigraphy in hypertrophic cardiomyopathy. Am J Cardiol
1989;64:498–503.
24. Sadoul N, Prasad K, Elliot PM, Bannerjee S, Frenneaux MP, McKenna WJ.
Prospective prognostic assessment of blood pressure response during exer-
cise in patients with hypertrophic cardiomyopathy. Circulation 1997;96:
2987–91.
1942 YOSHIDA ET AL. JACC Vol. 32, No. 7
ISCHEMIA AND BLOOD PRESSURE RESPONSE IN HCM December 1998:1938–42
